News

19th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders (SCWD), Washington, DC

By egalliOctober 9, 2026No Comments

December 10th – 12th, 2026 – Washington, DC
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

MitoXcel™ Geropeptide PTC-2105 Attenuates Terminal Lean-Mass Decline and Semaglutide-Associated Lean-Mass Loss in Aged Mice

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Washington, DC
December 10 – 12, 2026

Eos-SENOLYTIX-SCWD-2026-Accepted-With-Disclosures-October-2026

Next PostEos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

Leave a Reply Cancel Reply

You must be logged in to post a comment.

© 2026 MitoXcel™.